CO14 Identification & Use of Prognostic Variables (PVs)/Treatment Effect Modifiers (TEMs) in Indirect Treatment Comparisons (ITCs) By Systematic Literature Review (SLR): Case Study of Chimeric Antigen Receptor (CAR) T-Cell Therapies
ITCs estimate relative treatment effects not compared in head-to-head trials. According to the assumption of transitivity, trials must be comparable on factors including PVs/TEMs; however, these are not always consistently identified.
Source: Value in Health - Category: International Medicine & Public Health Authors: C.D. Igbelina, R. Campden, S. Grieve, D. Thakur Source Type: research
More News: International Medicine & Public Health | Study